Centiva Capital’s Fusion Pharmaceuticals FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-35,000
Closed -$746K – 2605
2024
Q1
$746K Buy
+35,000
New +$419K 0.02% 801

Centiva Capital's FUSN Position: Q2 2024 in Review

Centiva Capital sold out of Fusion Pharmaceuticals (FUSN) in Q2 2024, closing a stake of 35,000 shares — an estimated $746K sold.

Centiva Capital first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $746K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Centiva Capital reported no remaining Fusion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Centiva Capital sold 35,000 Fusion Pharmaceuticals shares in Q2 2024, an estimated $746K.
  • Centiva Capital first reported a position in Fusion Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Centiva Capital's Fusion Pharmaceuticals position peaked at $746K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q2 2024.

Based on Centiva Capital's 13F filing for Q2 2024, filed 14 Aug 2024.